Photo from wikipedia
Patients with cancer associated venous thromboembolism (VTE) have a higher risk of recurrent VTE than those without cancer and require long-term anticoagulation, but these patients are also at higher risk… Click to show full abstract
Patients with cancer associated venous thromboembolism (VTE) have a higher risk of recurrent VTE than those without cancer and require long-term anticoagulation, but these patients are also at higher risk of anticoagulant-related bleeding because of the frequent presence of disease- or treatment-related predispositions for bleeding.
Keywords:
patients cancer;
associated venous;
venous thromboembolism;
risk;
cancer associated;
cancer
Journal Title: Thrombosis and Haemostasis
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Thrombosis and Haemostasis
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!